Literature DB >> 9014765

p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment.

M Barbareschi, C Doglioni, S Veronese, M Bonzanini, P Dalla Palma, A L Harris, O Caffo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9014765     DOI： 10.1016/s0959-8049(96)00222-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.

Authors:  T G Mainprize; M D Taylor; J T Rutka; P B Dirks
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

3.  Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis.

Authors:  Zoë E Winters; Russell D Leek; Mike J Bradburn; Chris J Norbury; Adrian L Harris
Journal:  Breast Cancer Res       Date:  2003-10-03       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.